Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jinhai International Group Holdings Limited ( (HK:2225) ) just unveiled an announcement.
Jinhai Medical Technology Limited, a subsidiary of Jinhai International Group Holdings, is preparing to participate in the Eighth China International Import Expo in Shanghai. At the event, Jinhai Medical, in collaboration with Medtronic China, will introduce a new navigated spinal endoscope technique aimed at enhancing precision and efficiency in spinal surgeries. This development is expected to significantly impact the field of spinal surgery by facilitating broader clinical applications and reducing the learning curve for clinicians.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai International Group Holdings Limited, incorporated in the Cayman Islands, is an investment holding company. It operates through its subsidiaries in various sectors including manpower outsourcing, dormitory services, IT services, and construction ancillary services. Additionally, it provides minimally invasive surgery solutions and medical products, with a focus on endoscope products through its subsidiary Jinhai Medical, based in the PRC.
Average Trading Volume: 13,260,099
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.03B
See more data about 2225 stock on TipRanks’ Stock Analysis page.